The global graft versus host disease (GvHD) treatment market size was valued at USD 2.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2030. The rise in the elderly population and an increase in the occurrence of nephrological, leukem... Read More »
February 2024The global triamcinolone ointment chlorofluorocarbons market size is expected to grow at a Compound Annual Growth Rate (CAGR) of 1.6% from 2024 to 2030. Triamcinolone ointment, a topical corticosteroid, plays a vital role in treating various skin conditions like eczema, psoriasis, and de... Read More »
February 2024The global over the counter (OTC) drugs market size was estimated at USD 189.3 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.92 from 2024- 2030. The growth can be attributed to factors such as increasing consumer willingness to spend on OTC medication, growing consumer awarene... Read More »
February 2024The global ulcerative colitis market size was valued at USD 636.98 million in 2023 and is expected to grow at a CAGR of 6.43% during the forecast period 2024-2030. One of the key driving factors attributed to the growth of the ulcerative colitis market is the increasing prevalence of the... Read More »
February 2024The global tinea pedis treatment market was valued at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 7.09 % from 2024-2030. The market is experiencing growth due to the increasing prevalence of fungal foot infections globally, changing lifestyles, rising awareness about the... Read More »
February 2024The global ibuprofen API market size was valued at USD 700.8 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 1.17% from 2024 to 2030. The evolving API scenario in emerging economies, the increase in pharmaceutical and biopharmaceutical production, and t... Read More »
February 2024The global vitamin D therapy market size was valued at USD 2.04 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.06% from 2024 to 2030. The vitamin D therapy market is being driven by the growing awareness of the health benefits associated with vitamin... Read More »
February 2024The global methicillin-resistant staphylococcus aureus drugs market was valued at USD 2.15 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 5.51% from 2024 to 2030. This can be attributed to the pipeline space, and major pharmaceutical firms are advancin... Read More »
February 2024The global trachoma treatment market size was valued at USD 514.6 million in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.09% from 2024 to 2030. The market is experiencing growth due to the increasing incidence and prevalence of trachoma infectious disease. F... Read More »
February 2024The global influenza medications market size was valued at USD 928.9 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024-2030. The increasing incidence of influenza is set to drive the global demand for influenza medications. The growing ger... Read More »
February 2024The global anorexiants market size was valued around USD 900 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.77% from 2024 to 2030. Anorexiants, also known as appetite suppressants or weight loss medications, are drugs or pharmaceutical compounds spec... Read More »
February 2024The global oxytocin market is expected to grow at a CAGR of 6.1% from 2024 to 2030. Major factors contributing to the market growth include a rising incidence of pregnancy complications, a global increase in childbirth rates, and a growing awareness of induced labor and breastfeeding. Fo... Read More »
February 2024The global dacryocystitis market size expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2024 to 2030. The increasing prevalence of eye infections and technological advancements, growing clinical research, and subsequent new product launches boost the market growth. Fu... Read More »
February 2024The global compound camphor ointment market size was valued at USD 2.55 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 4.15% from 2024 to 2030. Compound camphor ointment acts as an analgesic and is used for chest congestion caused by cold & itching... Read More »
February 2024The global oncolytic virotherapy market was valued at USD 20.6 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 26.4% from 2024 to 2030. The rising prevalence of cancer and growing demand for gene therapy are the major factors driving the market for onco... Read More »
February 2024The global infectious enteritis treatment market size was valued at USD 453.46 million in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.09% from 2024 to 2030. The enduringly high prevalence of infectious enteritis, including conditions such as gastroenteritis ... Read More »
February 2024The global anticoagulants market size was valued at USD 34.8 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.74% from 2024 to 2030. The rising prevalence of cardiovascular diseases, such as deep vein thrombosis, pulmonary embolism, and atrial fibrilla... Read More »
February 2024The Canada Pharmaceutical market size was estimated at USD 48.59 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.88% over the forecast period. The market is driven by several factors, including an aging population, increasing healthcare expenditures, ... Read More »
February 2024The U.S. minor cannabinoids market size was estimated at USD 11.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 15.0% from 2024 to 2030. Consumers have access to a wide range of products containing minor cannabinoids, which cater to their specific hea... Read More »
January 2024The global ophthalmic drugs market size was estimated at USD 37.82 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.34% from 2024 to 2030. The market growth is attributed to rising prevalence of retinal disorders, advancement in drug delivery, and an ... Read More »
January 2024